| Financial Year |
March 31 2023 |
| Monetary Funds |
436,901,996.34 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
887,660.33 |
| Accounts Receivable |
2,095,785,701.88 |
| Advances to Suppliers |
247,731,563.74 |
| Other Receivables |
4,237,638.79 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,710,038,652.42 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
61,885,463.77 |
| Total Current Assets |
4,988,177,733.51 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
148,877,783.15 |
| Investment Properties |
-- |
| Fixed Assetes |
2,744,362,663.46 |
| Under-construction Projects |
294,542,581.99 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
225,837,406.77 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
8,736,834.40 |
| Deferred Income Tax Assets |
46,065,087.90 |
| Other Non-Current Assets |
105,824,588.56 |
| Sub-Total of Non-Current Assets |
3,591,813,923.99 |
| Total Assets |
8,579,991,657.50 |
| Short-Term Loans |
2,090,707,382.45 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,338,000,000.00 |
| Accounts Payable |
774,634,365.95 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
5,105,168.32 |
| Taxes Payable |
13,260,922.28 |
| Interest Payable |
-- |
| Dividend Payable |
378,363.00 |
| Other payables |
130,168,907.07 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
165,820.62 |
| Other Current Liabilities |
7,357,870.14 |
| Sub-Total of Current Liabilities |
4,396,999,725.90 |
| Long-term Loans |
750,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
150,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
848,852,729.05 |
| Total Liabilities |
5,245,852,454.95 |
| Paid-In Capital(Or Share Stock) |
747,735,596.00 |
| Capital Surplus |
1,477,119,015.57 |
| Surplus Reserve |
182,954,908.97 |
| LESS:Treasury Stock |
35,569,560.53 |
| Undistributed Profits |
787,247,935.01 |
| Minority Stockholder's Interest |
148,661,435.19 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,185,477,767.36 |
| Owner's Equity（Stockholder's Equity） |
3,334,139,202.55 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,579,991,657.50 |
